Hot News
by Ashis Sinha Two more vaccinations and one antiviral medicine have received emergency use authorization from the Government of India to help fight the continuing Covid-19 outbreak, informed health minister …
India approves 2 more Vaccines, 1 Pill to fight against COVID Read More
RNS I New Delhi: Covid-19 deterrent vaccine for children of age more than three years will be available in the country within next six months. Adar Poonawalla, CEO Serum Institute …
COVID-19 Vaccine for children 3+ in next 6 months : CEO SII Read More RNS: Covovax, another COVID-19 vaccine, being manufactured by Serum Institute of India, will be launched in October for adults and for children by the first quarter of 2022, said Adar …
COVID jab for kids by first quarter of 2022: Poonawalla Read More
RNS: The Serum Institute of India (SII) a Pune-based Pharma Company is on move to produce Novavax’s COVID-19 vaccine in India. The SII has carried out preparatory work on the …
Serum Institute to begin production of Covovax— Novavax’s COVID-19 vaccine in India Read More